Orange Book product · Generic (ANDA)
VELOSEF
CEPHRADINE
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CEPHRADINE
Strength
1GM/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 061976
Product number
004
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEPHRADINE
- —VELOSEF '250'Brand (NDA)
NDA 050548 · ERSANA
- —VELOSEFBrand (NDA)
NDA 050530 · BRISTOL MYERS SQUIBB
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062858 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062859 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062850 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062851 · BARR
- 1988CEPHRADINEGeneric (ANDA)
ANDA 062813 · VITARINE
- 1987CEPHRADINEGeneric (ANDA)
ANDA 062762 · IVAX SUB TEVA PHARMS
- 1987CEPHRADINEGeneric (ANDA)
ANDA 062683 · TEVA
- 1987CEPHRADINEGeneric (ANDA)
ANDA 062693 · TEVA
- —ANSPORGeneric (ANDA)
ANDA 061859 · GLAXOSMITHKLINE
- —VELOSEFGeneric (ANDA)
ANDA 061764 · APOTHECON
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
